Corrigendum to “ LncRNA CRNDE promotes the progression and angiogenesis of pancreatic cancer via miR-451a/CDKN2D axis” [Translational Oncology 14(7):101088]
Hong-Yan Zhu,
Yu-Jie Gao,
Yong Wang,
Chi Liang,
Zi-Xiang Zhang,
Yu Chen
Affiliations
Hong-Yan Zhu
Department of General Surgery, The First Affiliated Hospital of Soochow University, Suzhou, 215006, Jiangsu Province, China; Department of General Surgery, South China Hospital, Health Science Center, Shenzhen University, Shenzhen, 518116, Guangdong Province, P. R. China; Department of General Surgery, Suqian First Hospital, Suqian, 223800, Jiangsu Province, China
Yu-Jie Gao
Department of Hematology and Oncology, Shenzhen University General Hospital, Shenzhen 518055, Guangdong Province, China
Yong Wang
Department of General Surgery, Suqian First Hospital, Suqian, 223800, Jiangsu Province, China
Chi Liang
Department of General Surgery, Suqian First Hospital, Suqian, 223800, Jiangsu Province, China
Zi-Xiang Zhang
Department of General Surgery, The First Affiliated Hospital of Soochow University, Suzhou, 215006, Jiangsu Province, China; Corresponding author: Dr. Zi-Xiang Zhang, Department of General Surgery, The First Affiliated Hospital of Soochow University, No. 188 Shizi Street, Suzhou 215006, Jiangsu Province, China.
Yu Chen
Department of General Surgery, Suqian First Hospital, Suqian, 223800, Jiangsu Province, China; Dr. Yu Chen, Department of General Surgery, Suqian First Hospital, No. 120 Suzhi Road, Suqian 223800, Jiangsu Province, China.
